Thanks, Mr. Chair, and hello, colleagues.
Thank you to the witnesses for some great testimony today.
It's a real privilege to be here to listen to a lot of the recommendations from the witnesses today and the past witnesses via Zoom. We've heard, over the course of the last six or seven weeks, that research matters and health investment matters. MP Jaczek talked about the theme of a stronger role for the federal government, and that's coming from the witnesses. Even among us as parliamentarians, hearing from many that investing in health care is essential is just great to hear.
My questions will be focused on the cancer society. This one is close to my heart.
My mom has had stage four cancer for six years, and she was a former volunteer for the Canadian Cancer Society. I know vividly how the disease affects individuals, especially during this pandemic, in the impact it can have on a compromised immune system. It's a double anxiety.
Can you tell the committee what kind of COVID supports you're offering to Canadians and their families impacted by cancer? You talked a little about it, but I think it's important to talk about some of the specific things you're doing right now with respect to those families and those individuals impacted by cancer, as it relates to COVID-19.